Governors Lane LP Decreases Stock Holdings in Ventas, Inc. $VTR

Governors Lane LP decreased its holdings in shares of Ventas, Inc. (NYSE:VTR) by 30.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 384,596 shares of the real estate investment trust’s stock after selling 164,931 shares during the quarter. Ventas comprises about 1.8% of Governors Lane LP’s investment portfolio, making the stock its 11th largest position. Governors Lane LP’s holdings in Ventas were worth $29,760,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of VTR. Capital World Investors bought a new position in Ventas during the fourth quarter valued at $594,116,000. Norges Bank bought a new position in shares of Ventas in the fourth quarter worth about $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Ventas by 32,509.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock worth $359,722,000 after purchasing an additional 4,634,520 shares during the last quarter. Cohen & Steers Inc. grew its holdings in shares of Ventas by 228.1% in the fourth quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock worth $356,440,000 after purchasing an additional 3,202,323 shares during the last quarter. Finally, Daiwa Securities Group Inc. grew its holdings in shares of Ventas by 188.7% in the fourth quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock worth $364,119,000 after purchasing an additional 3,075,450 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. KeyCorp upped their price target on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Evercore restated an “outperform” rating and issued a $95.00 price target on shares of Ventas in a report on Wednesday, April 29th. BMO Capital Markets restated an “outperform” rating and issued a $100.00 price target on shares of Ventas in a report on Monday, May 4th. Citigroup upped their price target on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $96.41.

Insider Activity

In other news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by corporate insiders.

Ventas Stock Down 2.0%

Shares of Ventas stock opened at $82.21 on Thursday. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $91.06. The firm’s 50-day moving average is $85.15 and its two-hundred day moving average is $82.58. The stock has a market cap of $39.97 billion, a price-to-earnings ratio of 149.48, a PEG ratio of 1.80 and a beta of 0.71.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the company earned $0.84 earnings per share. The firm’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, research analysts expect that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is presently 378.18%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.